dc.contributor.author | Martin-Martin, Ines | |
dc.contributor.author | Molina, Ricardo | |
dc.contributor.author | Jimenez, Maribel | |
dc.date.accessioned | 2018-12-05T18:43:06Z | |
dc.date.available | 2018-12-05T18:43:06Z | |
dc.date.issued | 2015-11-16 | |
dc.identifier.citation | PLoS One. 2015 Nov 16;10(11):e0140722 | es_ES |
dc.identifier.issn | 1932-6203 | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/6770 | |
dc.description.abstract | BACKGROUND: Sand flies are hematophagous arthropods that act as vectors of Leishmania parasites. When hosts are bitten they develop cellular and humoral responses against sand fly saliva. A positive correlation has been observed between the number of bites and antibody levels indicating that anti-saliva antibody response can be used as marker of exposure to sand flies. Little is known about kinetics of antibodies against Phlebotomus perniciosus salivary gland homogenate (SGH) or recombinant salivary proteins (rSP). This work focused on the study of anti-P. perniciosus saliva antibodies in sera of mice and rabbits that were experimentally exposed to the bites of uninfected sand flies. METHODOLOGY/PRINCIPAL FINDINGS: Anti-saliva antibodies were evaluated by ELISA and Western blot. In addition, antibody levels against two P. perniciosus rSP, apyrase rSP01B and D7 related protein rSP04 were determined in mice sera. Anti-saliva antibody levels increased along the immunizations and correlated with the number of sand fly bites. Anti-SGH antibody levels were detected in sera of mice five weeks after exposure, and persisted for at least three months. Anti-apyrase rSP01B antibodies followed similar kinetic responses than anti-SGH antibodies while rSP04 showed a delayed response and exhibited a greater variability among sera of immunized mice. In rabbits, anti-saliva antibodies appeared after the second week of exposure and IgG antibodies persisted at high levels, even 7 months post-exposure. CONCLUSIONS/SIGNIFICANCE: Our results contributed to increase the knowledge on the type of immune response P. perniciosus saliva and individual proteins elicited highlighting the use of rSP01B as an epidemiological marker of exposure. Anti-saliva kinetics in sera of experimentally bitten rabbits were studied for the first time. Results with rabbit model provided useful information for a better understanding of the anti-saliva antibody levels found in wild leporids in the human leishmaniasis focus in the Madrid region, Spain. | es_ES |
dc.description.sponsorship | This study was partially funded by the Spanish Ministry of Science & Innovation (Project AGL2008-01592) and by the EU grant FP7-2011-261504 EDENext. The paper is catalogued by the EDENext Steering Committee as EDENext371 (http://www.edenext.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Public Library of Science (PLOS) | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject.mesh | Animals | es_ES |
dc.subject.mesh | Antibodies | es_ES |
dc.subject.mesh | Blotting, Western | es_ES |
dc.subject.mesh | Disease Models, Animal | es_ES |
dc.subject.mesh | Enzyme-Linked Immunosorbent Assay | es_ES |
dc.subject.mesh | Female | es_ES |
dc.subject.mesh | Immunoglobulin G | es_ES |
dc.subject.mesh | Leishmania | es_ES |
dc.subject.mesh | Leishmaniasis | es_ES |
dc.subject.mesh | Mice | es_ES |
dc.subject.mesh | Mice, Inbred BALB C | es_ES |
dc.subject.mesh | Phlebotomus | es_ES |
dc.subject.mesh | Rabbits | es_ES |
dc.subject.mesh | Recombinant Proteins | es_ES |
dc.subject.mesh | Saliva | es_ES |
dc.subject.mesh | Salivary Glands | es_ES |
dc.subject.mesh | Salivary Proteins and Peptides | es_ES |
dc.subject.mesh | Spain | es_ES |
dc.title | Kinetics of Anti-Phlebotomus perniciosus Saliva Antibodies in Experimentally Bitten Mice and Rabbits | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Atribución 4.0 Internacional | * |
dc.identifier.pubmedID | 26569103 | es_ES |
dc.format.volume | 10 | es_ES |
dc.format.number | 11 | es_ES |
dc.format.page | e0140722 | es_ES |
dc.identifier.doi | 10.1371/journal.pone.0140722 | es_ES |
dc.contributor.funder | Unión Europea. Comisión Europea. 7 Programa Marco | |
dc.contributor.funder | Ministerio de Ciencia e Innovación (España) | |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 1932-6203 | es_ES |
dc.relation.publisherversion | https://doi.org/10.1371/journal.pone.0140722 | es_ES |
dc.identifier.journal | PloS one | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/FP7/261504/ | es_ES |
dc.rights.accessRights | open access | es_ES |